IDEC 132

Drug Profile

IDEC 132

Alternative Names: 9-AC; 9-Amino-20-S-camptothecin; 9-aminocamptothecin; NSC 603071

Latest Information Update: 10 Oct 2000

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Developer IDEC Pharmaceuticals; Nonindustrial source
  • Class Alkaloids; Camptothecins; Small molecules
  • Mechanism of Action DNA topoisomerase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 10 Oct 2000 A clinical study has been added to the therapeutic trials section
  • 06 Mar 2000 A study has been added to the adverse events and therapeutic trials sections
  • 10 Aug 1999 Discontinued-II for Cancer in USA (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top